Myo-Inositol
Also sold as: Inositol, Myo & D-Chiro Inositol
Best-in-class: Myo-Inositol
A B-vitamin-like compound and insulin second-messenger with strong evidence for PCOS, insulin sensitivity, and — at higher doses — anxiety and mood.
Myo-Inositol quick facts
| Suggested dose | 2–4 g daily for metabolic/PCOS; up to 12–18 g for mood. |
| How often | Daily |
| Who it's for | PCOS, insulin sensitivity, cycle health and anxiety/mood. |
| Best-in-class brand | Myo-Inositol |
The strongest evidence of anything in this category, and it's specific: PCOS, where trials show restored ovulation, improved insulin markers and lower androgens, with a safety profile far better than metformin's. It's also used for anxiety and OCD at much higher doses with more preliminary support. Effects take around three months, so it needs patience. Doses are in grams, not milligrams, which surprises people. Very well tolerated — loose stool at the top end is the main complaint.
How Myo-Inositol actually works
Inositol isn't a vitamin but behaves like one, and it works as a second messenger — it's the molecule the insulin receptor uses to relay its signal inside the cell. In insulin resistance that relay is impaired, and in PCOS specifically there's evidence of a defect in converting myo-inositol to its d-chiro form in certain tissues. Restoring the supply improves insulin signaling, and because ovarian androgen production is driven by insulin, that improvement cascades into lower testosterone and restored ovulation. The 40:1 myo to d-chiro ratio used in products mirrors the ratio found in follicular fluid.
Where to get Myo-Inositol
Find Myo-Inositol on iHerb →The evidence for Myo-Inositol
Graded by what exists behind each claim.
✅ Clinically validated
- Robust RCT support for improving insulin sensitivity, cycle regularity and ovulation in PCOS.
- Higher doses (12–18 g) studied for anxiety, OCD and panic.
📊 Correlative data
- Insulin resistance underlies many PCOS and metabolic patterns inositol improves.
🧪 Theoretical / extrapolated benefits
- The 40:1 myo:d-chiro ratio is favored for PCOS — well-supported.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Myo-Inositol actually does
There are 9 stereoisomers of inositol and 2 of them are sold, which is where the entire page starts. Myo-inositol is the abundant one; D-chiro-inositol is made from it by a tissue-specific epimerase. Both are cyclohexanehexols differing only in the orientation of 1 hydroxyl group, and that single stereochemical difference sends them into 2 different signaling systems.
Their jobs are not interchangeable, and the tissue ratio proves it. Myo-inositol is the precursor for inositol 1,4,5-trisphosphate, the second messenger that releases calcium from the endoplasmic reticulum downstream of phospholipase C. D-chiro-inositol is incorporated into an inositol phosphoglycan mediator involved in glycogen synthesis. The myo to D-chiro ratio in healthy ovarian follicular fluid is approximately 100 to 1, while in muscle and liver it is far lower Fedeli 2023.
The proposed defect in polycystic ovary syndrome is an epimerase problem, and the direction matters. The prevailing account is that insulin-driven overactivity of the epimerase in the ovary depletes myo-inositol and accumulates D-chiro-inositol locally, impairing follicle-stimulating hormone signaling, which depends on the myo-inositol messenger. The paradox is that the tissue needing more myo-inositol is the same tissue converting it away Lentini 2025.
Which is why the wrong isomer is not merely useless, it is directional. High doses of D-chiro-inositol alone induced a polycystic ovary-like syndrome and other alterations in mouse ovaries Bevilacqua 2021. That is a supplement reproducing the phenotype it is sold to treat, in an animal model, at high dose. It is the single most important experiment in this literature.
And the insulin connection is what links ovary to metabolism. Insulin resistance drives ovarian theca cell androgen production through the insulin receptor and insulin-like growth factor 1 receptor, so lowering fasting insulin lowers androgen output. That is why the same molecule has both metabolic and reproductive endpoints, and why fasting insulin is the marker the predictions below lean on.
Cell, rodent, human — and where it stops
This is one of the better-evidenced supplements in the catalog and the evidence is unusually specific about ratio.
The mouse experiment that defines the risk. High-dose D-chiro-inositol alone produced a polycystic ovary-like syndrome in mouse ovaries Bevilacqua 2021. A rodent result showing harm from an isomer that is sold on shelves is exactly the sort of finding that should shape a purchase and almost never reaches a label.
The human trials use a defined ratio. Myo-inositol and D-chiro-inositol in a 40 to 1 ratio were tested on hormonal and metabolic profile in women with polycystic ovary syndrome classified as phenotype A Pustotina 2024, and an update on the combination sets out where the ratio came from and what it is supposed to do Lete 2024.
The comparator that matters is a drug. Combined myo-inositol and D-chiro-inositol was compared against metformin across polycystic ovary syndrome phenotypes in a prospective clinical trial, with ovarian function, ovulation and stress response as endpoints Gul 2025. Comparing a supplement against the standard insulin-sensitizing drug rather than against placebo is the right design and it is rare.
Fertility outcomes have been pooled. The effect of myo-inositol on assisted reproductive technology outcomes in women with polycystic ovarian syndrome has been assessed in a systematic review and meta-analysis of randomized clinical trials Sene 2025. Oocyte quality and clinical pregnancy rate are outcomes a person can act on rather than surrogate markers.
The specific obstacle to transfer is that phenotype matters. Polycystic ovary syndrome is a heterogeneous diagnosis with 4 Rotterdam phenotypes, and the trials increasingly stratify by them Pustotina 2024 Gul 2025. Results in phenotype A, the full hyperandrogenic anovulatory presentation, do not automatically extend to a woman with regular cycles taking inositol for insulin sensitivity, and the reviews are explicit that lessons are still being learned Lentini 2025.
Myo-Inositol — which form, and does it matter
The ratio is the specification, and 40 to 1 is not arbitrary. It approximates the plasma ratio of the 2 isomers in healthy women, and it is the ratio used in the trials Pustotina 2024 Lete 2024. A product selling D-chiro-inositol alone, or at a much richer ratio such as 5 to 1, is not a stronger version of the studied product; it is a different one with an animal signal pointing the wrong way Bevilacqua 2021.
The dose is in grams and that surprises people. Trials use about 2,000 mg of myo-inositol twice daily, 4 g in total, with 50 mg of D-chiro-inositol to give the 40 to 1 ratio Pustotina 2024. A 500 mg capsule is an eighth of the studied daily dose, and reaching 4 g from capsules means 8 of them.
Powder against capsule is a practical form question here more than usual. At 4 g daily the capsule count is the reason people stop, and myo-inositol powder is mildly sweet and dissolves readily. This is a rare case where the dosage form is the main determinant of whether the studied dose is ever taken.
Inositol hexanicotinate is a completely different product and shares a shelf. It is a niacin ester used for lipid purposes, sometimes labeled 'no-flush niacin'. It is not myo-inositol, it does not deliver a meaningful inositol dose, and buying it for the indications on this page is a substitution based on a shared word.
And phytic acid is not a source. Inositol hexaphosphate in grains and legumes is the storage form, and human phytase activity is low, so dietary phytate is a poor inositol source. Endogenous synthesis from glucose 6-phosphate by inositol-3-phosphate synthase, plus a few hundred milligrams a day from food, is the baseline any supplement adds to Fedeli 2023.
What would have to be true, and how you would know it was not
1. The metabolic prediction, at 12 weeks. Fasting insulin, fasting glucose and a homeostatic model assessment of insulin resistance calculated from them, plus hemoglobin A1c. Prediction: a measurable fall in fasting insulin and in the resistance index on 4 g of myo-inositol daily in someone with an elevated baseline Gul 2025. In someone whose fasting insulin is already below 6 microinternational units per milliliter, predict no change.
2. The androgen prediction, which follows the insulin one. Total testosterone, sex hormone binding globulin and the free androgen index at baseline and 12 weeks. Prediction: free androgen index falls, driven more by a rise in sex hormone binding globulin than by a fall in total testosterone, because insulin suppresses hepatic sex hormone binding globulin production Pustotina 2024.
3. The ovulation prediction, on a real clock. Cycle length and luteal progesterone drawn 7 days after a suspected ovulation, or a urinary luteinizing hormone kit across 3 cycles. Prediction: measurable improvement in ovulation frequency by cycle 3, which is why the common advice to allow 3 months is a pharmacodynamic statement rather than patience Lete 2024.
4. Predict the wrong ratio underperforms or reverses. If someone is taking D-chiro-inositol alone or a low-ratio product, predict less improvement in ovulation than on the 40 to 1 combination, and consider the mouse data when interpreting a worsening Bevilacqua 2021. This is the prediction that would matter most and the one nobody tests, because almost nobody records which ratio they bought.
5. The fertility prediction, stated at the level the evidence supports. In assisted reproduction, the pooled endpoints are oocyte quality and clinical pregnancy rate Sene 2025. Prediction: a modest improvement in oocyte quality metrics rather than a large change in live birth rate, since that is where the pooled effect sits and overpromising here has a real human cost.
What nobody has tested yet
Nobody has run a proper ratio-ranging trial. The 40 to 1 ratio comes from the plasma ratio in healthy women rather than from a trial that compared 40 to 1 against 20 to 1 against myo-inositol alone Lete 2024. Given that the isomers pull in opposite directions in the ovary Bevilacqua 2021, that comparison is the most important missing study in the field.
Nobody knows whether the D-chiro component is needed at all. Myo-inositol alone has evidence in assisted reproduction Sene 2025 and the combination has evidence in phenotype A Pustotina 2024. A 3-arm trial of myo-inositol alone against the 40 to 1 combination against placebo would settle it and has not been published.
Nobody has matched treatment to phenotype prospectively. The trials stratify after the fact Gul 2025, and no study has randomized within each Rotterdam phenotype to test whether the effect is concentrated in one of them Lentini 2025.
And the male and non-reproductive uses are barely studied. Inositol at 12 to 18 g daily has been used for anxiety and obsessive-compulsive symptoms on the basis of small older trials, and the modern literature has not revisited it. The dose is 3 to 4 times the metabolic dose and its evidence base is far thinner than the reproductive one.
Myo-Inositol — its own safety story, not its category's
The dose-limiting effect is osmotic and predictable. Inositol is a small, water-soluble polyol, and unabsorbed material in the gut draws in water. Nausea, gas and loose stool appear above about 12 g daily and are the reason the high-dose psychiatric protocols are hard to sustain. At the metabolic dose of 4 g, tolerance is generally good.
The risk that is specific to this product is buying the wrong isomer. High-dose D-chiro-inositol alone induced a polycystic ovary-like phenotype in mouse ovaries Bevilacqua 2021. That is a supplement-specific hazard with a mechanism, and it is not transferable to myo-inositol, which is why the ratio section above is a safety section as much as a form one.
Restored ovulation is a safety issue that nobody frames as one. If this works as intended in an anovulatory woman, fertility returns Lete 2024. Someone taking it for insulin sensitivity or for cycle regularity, and relying on anovulation for contraception, needs to know that before it happens rather than after.
Two medication interactions with a mechanism. Metformin shares the insulin-sensitizing target, so combining the 2 is additive rather than duplicative and glucose should be monitored Gul 2025; and anyone on insulin or a sulfonylurea has the usual hypoglycemia risk when a second glucose-lowering intervention is added.
Pregnancy is where the evidence is genuinely encouraging and the decision still belongs to a clinician. Myo-inositol has been studied for gestational diabetes prevention and in assisted reproduction Sene 2025, and pregnancy is not a setting for self-directed supplementation. Nothing on this page is medical advice or a diagnosis, polycystic ovary syndrome is a medical diagnosis that needs a clinician, and these statements have not been evaluated by the Food and Drug Administration.
Sources read for this page
- Bevilacqua A. High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries. Int J Mol Sci 2021 · PMID 34073634
- Fedeli V. The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results. Int J Mol Sci 2023 · PMID 37047265
- Pustotina O. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria. Gynecol Obstet Invest 2024 · PMID 38295772
- Lete I. Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome. Gynecol Endocrinol 2024 · PMID 38239032
- Lentini G. PCOS and Inositols - Advances and Lessons We are Learning. A Narrative Review. Drug Des Devel Ther 2025 · PMID 40420946
- Gul M. Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial. Naunyn Schmiedebergs Arch Pharmacol 2025 · PMID 39847053
- Sene AA. The effect of myo-inositol on assisted reproductive technology outcomes in women with polycystic ovarian syndrome: A systematic review and meta-analysis of randomized clinical trial studies. Int J Reprod Biomed 2025 · PMID 40989082
How you would know if it worked
These are the markers that recommend this product on their own pages, so they are the ones that should move if it is doing what it is sold for.
- Fasting Insulin Retest: Every 3–6 months, or 8–12 weeks after an intervention.
- HbA1c (Hemoglobin A1c) — Berberine, myo-inositol, magnesium, chromium, alpha-lipoic acid, cinnamon (modest) Retest: Every 3 months (matches red cell lifespan).
- Thyroid Antibodies (TPO + TgAb) — Vitamin D (commonly low in autoimmunity), and myo-inositol combined with selenium shows promise in trials Retest: Annually if positive; TSH monitoring matters more than repeat antibody titers.
- Androstenedione — Myo-inositol (strong PCOS evidence), berberine, magnesium — all via insulin sensitivity Retest: 12 weeks after intervention.
The cheapest panel carrying Fasting Insulin and at least one other of these is Am I Prediabetic?, at $19 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Myo-Inositol — safety & side effects
- Among the better-tolerated things in this category. Nausea, gas and diarrhea above about 12 g/day.
- Mild blood-glucose lowering — worth noting alongside diabetes medication, though clinically it rarely causes problems.
- Well studied in PCOS and generally regarded as safe in pregnancy, which is unusual here. Can be mildly activating; dose earlier if it affects sleep.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
Build your foundation with Coach Cam
The full Supplement Vault — 371 products across 14 categories with clinical, correlative & theoretical evidence, plus my Thorne partner links — lives inside Skool alongside 278 peptides.
Join Skool — $10/mo →Bloodwork to run alongside Myo-Inositol
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Fasting Insulin | Inositol's best evidence is insulin sensitivity in PCOS |
| HbA1c (Hemoglobin A1c) | The slower confirmation |
| Total Testosterone | Falls when the insulin picture improves — that's the point |
| SHBG (Sex Hormone-Binding Globulin) | Rises as insulin falls, which lowers free androgens |
The PCOS Workup panel covers these in one order — 10 markers, $225.90 with the discount applied.
Check results you already have → · All 103 markers A–Z
Myo-Inositol — frequently asked questions
What is Myo-Inositol?
A B-vitamin-like compound and insulin second-messenger with strong evidence for PCOS, insulin sensitivity, and — at higher doses — anxiety and mood.
What is the suggested dose of Myo-Inositol?
2–4 g daily for metabolic/PCOS; up to 12–18 g for mood. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
What are the researched benefits of Myo-Inositol?
Robust RCT support for improving insulin sensitivity, cycle regularity and ovulation in PCOS.
Who is Myo-Inositol for?
PCOS, insulin sensitivity, cycle health and anxiety/mood.
Where can I buy Myo-Inositol?
Coach Cam sources Myo-Inositol from vetted, top-rated brands on iHerb — use the buy link on this page.
Myo-Inositol inside a finished plan
One arm of 5 Protocol Blueprints, free to read in full.
What Myo-Inositol is used for
Myo-Inositol appears under 5 goals in the goal router.
Related Metabolic & Weight supplements
Where this goes next
Myo-Inositol is the insulin-sensitivity arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.